Live Breaking News & Updates on Haroldc Schott

Stay updated with breaking news from Haroldc schott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cancer stem cell test can lead to increased survival for patients with glioblastoma

New multi-institutional phase 3 clinical trial data published May 2 in Cell Reports Medicine found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor. ....

Jagan Valluri , Paolo Claudio , Haroldc Schott , Emily Henderson , Rekha Chaudhary , Mario Zuccarello , University Of Cincinnati Soma Sengupta , Uc Health , University Of Cincinnati Cancer Center , National Institutes Of Health , Brain Tumor Center , Cell Reports Medicine , Soma Sengupta , Cincinnati Cancer Center , Pier Paolo Claudio , Endowed Chair , Molecular Therapeutics , Tom Mischell , National Institutes , Brain Tumor , Clinical Trial , Stem Cells ,

Study: ChemoID platform-predicted treatments

The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor. ....

Rekha Chaudhary , Jagan Valluri , Mario Zuccarello , Paolo Claudio , Haroldc Schott , Uc Health , National Institutes Of Health , Brain Tumor Center , University Of Cincinnati Soma Sengupta , University Of Cincinnati Cancer Center , Method Of Research , Reports Medicine , Soma Sengupta , Cincinnati Cancer Center , Pier Paolo Claudio , Endowed Chair , Molecular Therapeutics , Tom Mischell , National Institutes ,

Practicing integrative neuro-oncology to improve care for brain tumor patients

The University of Cincinnati's Soma Sengupta, MD, PhD, published an article in the Journal of Neuro-Oncology April 25 discussing her journey and approach to practicing integrative neuro-oncology. ....

Emily Henderson , Haroldc Schott , University Of Cincinnati , Uc Health , Brain Tumor Center , University Of Arizona , Andrew Weil Integrative Medicine Center , University Of Cincinnati Soma Sengupta , Soma Sengupta , Neuro Oncology April , Endowed Chair , Molecular Therapeutics , Tom Mischell Funds , Brain Tumor , Neuro Oncology ,

Improvement seen in PPID horses given pergolide long term

Long-term study followed 28 horses and 2 ponies being treated with pergolide for PPID over 13 year-period. ....

United States , San Antonio , Wikimedia Commons , Julier Strachota , Haroldc Schott , Judithv Marteniuk , Harold Schott , Kentr Refsal , Proceedings American Association Of Equine Practitioners , Michigan State University , American Association Of Equine Practitioners , Equine Cushing , Equine Practitioners , Annual Convention , Term Response , Pituitary Pars Intermedia Dysfunction , Proceedings American Association ,

Pergolide Study Shows Long-Term Improvement in PPID Horses – The Horse

A 13-year study showed this PPID treatment improves horses’ clinical signs and quality of life over prolonged periods. ....

United States , Michigan State University , East Lansing , San Antonio , Haroldc Schott , American Association Of Equine Practitioners , Equine Practitioners ,